Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Incorporating essential elements into your retirement financial plan at 50 is vital. Find out what you need to secure your future.
23,888 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Tether froze 131 TRON wallets tied to ISIS-K after sanctions added 134 crypto addresses, marking a watershed moment f...
A major AI feature sparked controversy in the writing world. Grammarly paused its 'Expert Review' tool after authors ...
Chipmakers led a broad rebound as the S&P 500 climbed on June 8, 2026. The session showed tech rotation returning to ...
Reddit and Chewy just reported fresh quarters that highlight two distinct paths in the internet economy. One monetize...
SolarEdge leads a solar-stock surge, jumping about 14% as Canadian Solar adds strength. Investors cite AI infrastruct...
Goldman Sachs expands its US Conviction List with four new names pegged for double-digit upside, signaling a continue...
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Oracle is racing to reinvent itself as an AI-enabled cloud platform, funding AI infrastructure with debt while juggli...
Emerging markets are outpacing the S&P 500 in 2026, with EEM posting a double-digit lead year-to-date. The rally cent...
Tesla could redefine AI profitability by owning the stack from hardware to the finished product. A new investment the...
Silver trades near $68 per ounce as a hawkish Federal Reserve keeps the dollar firm. The market faces a critical test...